205 related articles for article (PubMed ID: 35266114)
81. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
82. Intracellular itinerary of internalised β-secretase, BACE1, and its potential impact on β-amyloid peptide biogenesis.
Chia PZ; Toh WH; Sharples R; Gasnereau I; Hill AF; Gleeson PA
Traffic; 2013 Sep; 14(9):997-1013. PubMed ID: 23773724
[TBL] [Abstract][Full Text] [Related]
83. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
84. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
[TBL] [Abstract][Full Text] [Related]
85. New players in old amyloid precursor protein-processing pathways.
Rossner S
Int J Dev Neurosci; 2004 Nov; 22(7):467-74. PubMed ID: 15465276
[TBL] [Abstract][Full Text] [Related]
86. beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein.
Yamakawa H; Yagishita S; Futai E; Ishiura S
J Biol Chem; 2010 Jan; 285(3):1634-42. PubMed ID: 19926793
[TBL] [Abstract][Full Text] [Related]
87. Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid.
Chen Y; Huang X; Zhang YW; Rockenstein E; Bu G; Golde TE; Masliah E; Xu H
J Neurosci; 2012 Aug; 32(33):11390-5. PubMed ID: 22895721
[TBL] [Abstract][Full Text] [Related]
88. The cellular expression and proteolytic processing of the amyloid precursor protein is independent of TDP-43.
Hicks DA; Jones AC; Pickering-Brown SM; Hooper NM
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32301481
[TBL] [Abstract][Full Text] [Related]
89. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
90. GGA1 regulates signal-dependent sorting of BACE1 to recycling endosomes, which moderates Aβ production.
Toh WH; Chia PZC; Hossain MI; Gleeson PA
Mol Biol Cell; 2018 Jan; 29(2):191-208. PubMed ID: 29142073
[TBL] [Abstract][Full Text] [Related]
91. Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.
Vorobyeva AG; Lee R; Miller S; Longen C; Sharoni M; Kandelwal PJ; Kim FJ; Marenda DR; Saunders AJ
J Biol Chem; 2014 Nov; 289(48):33258-74. PubMed ID: 25281744
[TBL] [Abstract][Full Text] [Related]
92. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
[TBL] [Abstract][Full Text] [Related]
93. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
[TBL] [Abstract][Full Text] [Related]
94. Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity.
Durairajan SSK; Chirasani VR; Shetty SG; Iyaswamy A; Malampati S; Song J; Liu L; Huang J; Senapati S; Li M
Curr Alzheimer Res; 2017; 14(11):1229-1237. PubMed ID: 28413985
[TBL] [Abstract][Full Text] [Related]
95. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
[TBL] [Abstract][Full Text] [Related]
96. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
97. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
Devi L; Ohno M
Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
[TBL] [Abstract][Full Text] [Related]
98. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
Read J; Suphioglu C
Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
[TBL] [Abstract][Full Text] [Related]
99. Measurement of cellular beta-site of APP cleaving enzyme 1 activity and its modulation in neuronal assay systems.
Volbracht C; Penzkofer S; Mansson D; Christensen KV; Fog K; Schildknecht S; Leist M; Nielsen J
Anal Biochem; 2009 Apr; 387(2):208-20. PubMed ID: 19454261
[TBL] [Abstract][Full Text] [Related]
100. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
